Table 4 Association of cardiovascular comorbidities with the use of glucocorticoids
Glucocorticoids | |||||
|---|---|---|---|---|---|
Yes n*(%) | No n*(%) | PRˆ (IC95%) | p‡ | ||
Cardiovascular Comorbidities | Yes | 322 (66.9) | 388 (66.1) | 0.921 (0.842–1.007) | 0.070 |
No | 207 (39.1) | 199 (33.9) | 1.154 (0.988–1.348) | ||
Systemic Arterial Hypertension | Yes | 257 (48.6) | 300 (51.1) | 0.951 (0.845–1.070) | 0.400 |
No | 272 (51.4) | 287 (48.9) | 1.052 (0.935–1.182) | ||
Dyslipidemia | Yes | 151 (28.5) | 212 (36.1) | 0.790 (0.665–0.939) | 0.007 |
No | 378 (71.5) | 375 (63.9) | 1.119 (1.031–1.213) | ||
Diabetes Mellitus | Yes | 74 (14) | 92 (15.7) | 0.893 (0.673–1.184) | 0.430 |
No | 455 (86) | 495 (84.3) | 1.020 (0.971–1.071) | ||
Congestive Heart Failure | Yes | 11 (2.1) | 13 (2.2) | 0.939 (0.424–2.078) | 0.876 |
No | 518 (97.9) | 574 (97.8) | 1.001 (0.984–1.019) | ||
Cerebrovascular Disease | Yes | 12 (2.3) | 12 (2) | 1.110 (0.503–2.449) | 0.797 |
No | 517 (97.7) | 575 (98) | 0.998 (0.980–1.015) | ||
Acute Myocardial Infarction | Yes | 8 (1.5) | 9 (1.5) | 0.986 (0.383–2.538) | 0.977 |
No | 521 (98.5) | 578 (98.5) | 1.000 (0.986–1.015) | ||
Peripheral Vascular Disease | Yes | 4 (0.8) | 4 (0.7) | 1.110 (0.279–4.415) | 1.000 |
No | 525 (99.2) | 583 (99.3) | 0.999 (0.989–1.009) | ||